Consequences of gaining an extra chromosome.

Aneuploidy Down syndrome Human trisomy Nuclear morphology Serine synthesis Sphingolipids Yeast

Journal

Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology
ISSN: 1573-6849
Titre abrégé: Chromosome Res
Pays: Netherlands
ID NLM: 9313452

Informations de publication

Date de publication:
25 08 2023
Historique:
received: 11 05 2023
accepted: 30 07 2023
revised: 18 07 2023
medline: 28 8 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: epublish

Résumé

Mistakes in chromosome segregation leading to aneuploidy are the primary cause of miscarriages in humans. Excluding sex chromosomes, viable aneuploidies in humans include trisomies of chromosomes 21, 18, or 13, which cause Down, Edwards, or Patau syndromes, respectively. While individuals with trisomy 18 or 13 die soon after birth, people with Down syndrome live to adulthood but have intellectual disabilities and are prone to multiple diseases. At the cellular level, mistakes in the segregation of a single chromosome leading to a cell losing a chromosome are lethal. In contrast, the cell that gains a chromosome can survive. Several studies support the hypothesis that gaining an extra copy of a chromosome causes gene-specific phenotypes and phenotypes independent of the identity of the genes encoded within that chromosome. The latter, referred to as aneuploidy-associated phenotypes, are the focus of this review. Among the conserved aneuploidy-associated phenotypes observed in yeast and human cells are lower viability, increased gene expression, increased protein synthesis and turnover, abnormal nuclear morphology, and altered metabolism. Notably, abnormal nuclear morphology of aneuploid cells is associated with increased metabolic demand for de novo synthesis of sphingolipids. These findings reveal important insights into the possible pathological role of aneuploidy in Down syndrome. Despite the adverse effects on cell physiology, aneuploidy is a hallmark of cancer cells. Understanding how aneuploidy affects cell physiology can reveal insights into the selective pressure that aneuploid cancer cells must overcome to support unlimited proliferation.

Identifiants

pubmed: 37620607
doi: 10.1007/s10577-023-09732-w
pii: 10.1007/s10577-023-09732-w
pmc: PMC10449985
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

24

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD107873
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Nature. 2021 Mar;591(7848):137-141
pubmed: 33361815
Nat Rev Genet. 2012 Jun 18;13(7):493-504
pubmed: 22705668
Nature. 2010 Nov 11;468(7321):321-5
pubmed: 20962780
Mol Biol Cell. 2000 Dec;11(12):4241-57
pubmed: 11102521
Mol Biol Cell. 2012 May;23(10):1986-97
pubmed: 22456505
Eur J Hum Genet. 2010 Mar;18(3):265-71
pubmed: 19568271
Nature. 1959 Jan 31;183(4657):302-3
pubmed: 13632697
Nature. 2014 Apr 17;508(7496):345-50
pubmed: 24740065
Cell Syst. 2018 Dec 26;7(6):580-589.e4
pubmed: 30553725
Genes Dev. 2012 Dec 15;26(24):2696-708
pubmed: 23222101
Genes Dev. 2019 Aug 1;33(15-16):1031-1047
pubmed: 31196865
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12644-9
pubmed: 22802626
Cell. 2011 Feb 18;144(4):499-512
pubmed: 21315436
N Engl J Med. 2004 Sep 16;351(12):1227-38
pubmed: 15371580
Nat Rev Genet. 2011 Nov 29;13(1):5
pubmed: 22124481
Birth Defects Orig Artic Ser. 1979;15(1):3-14
pubmed: 444646
WormBook. 2005 Jun 25;:1-9
pubmed: 18023124
Biochim Biophys Acta. 2002 Jun 13;1583(1):13-25
pubmed: 12069845
Proc Natl Acad Sci U S A. 1921 May;7(5):148-52
pubmed: 16586825
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33526671
Trends Genet. 1995 Jan;11(1):17-22
pubmed: 7900190
BMC Genet. 2009 Jul 13;10:36
pubmed: 19594932
Science. 2006 Jul 21;313(5785):367-70
pubmed: 16857942
Genetics. 1992 Nov;132(3):665-73
pubmed: 1468625
Cell. 2018 Aug 23;174(5):1293-1308.e36
pubmed: 29961579
Cell. 2010 Oct 1;143(1):71-83
pubmed: 20850176
Nat Rev Genet. 2020 Jan;21(1):44-62
pubmed: 31548659
Nat Rev Mol Cell Biol. 2022 Apr;23(4):231-249
pubmed: 35013589
J Cell Biol. 2013 Apr 1;201(1):11-21
pubmed: 23547028
Science. 2017 Jan 20;355(6322):
pubmed: 28104840
Nat Commun. 2023 Mar 11;14(1):1353
pubmed: 36906648
Cold Spring Harb Perspect Biol. 2016 Apr 01;8(4):a019083
pubmed: 26254313
Nature. 2022 Jun;606(7916):984-991
pubmed: 35705804
Nature. 2012 Jun 20;486(7403):405-9
pubmed: 22722202
Nat Rev Mol Cell Biol. 2008 Feb;9(2):139-50
pubmed: 18216770
Science. 2008 Oct 31;322(5902):703-9
pubmed: 18974345
Curr Opin Genet Dev. 2013 Apr;23(2):109-15
pubmed: 23465885
Cell. 2017 Apr 6;169(2):229-242.e21
pubmed: 28388408
EMBO J. 2014 Oct 16;33(20):2374-87
pubmed: 25205676
Nat Genet. 2000 Jul;25(3):333-7
pubmed: 10888885
Genes Dev. 2016 Oct 15;30(20):2259-2271
pubmed: 27807036
Mol Syst Biol. 2012;8:608
pubmed: 22968442
Cancer Res. 2004 Oct 1;64(19):6941-9
pubmed: 15466185
Elife. 2014 Jul 29;3:e03023
pubmed: 25073701
Nature. 2023 Jul;619(7968):176-183
pubmed: 37286593
Nature. 1997 Mar 20;386(6622):275-9
pubmed: 9069285
Cell Rep. 2017 Dec 26;21(13):3807-3818
pubmed: 29281829
Nat Rev Dis Primers. 2020 Feb 6;6(1):9
pubmed: 32029743
Elife. 2015 May 08;4:
pubmed: 25955966
Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):21010-5
pubmed: 23197825
Nat Rev Cancer. 2004 Sep;4(9):677-87
pubmed: 15343274
J Cell Sci. 2008 Jan;121 Suppl 1:1-84
pubmed: 18089652
Genetics. 2007 Jan;175(1):65-76
pubmed: 17057230
Genome Res. 2020 Jun;30(6):860-873
pubmed: 32461223
Nat Rev Cancer. 2013 Aug;13(8):572-83
pubmed: 23822983
Nat Commun. 2019 Oct 18;10(1):4766
pubmed: 31628327
Science. 2006 May 19;312(5776):1059-63
pubmed: 16645051
Curr Genet. 2019 Dec;65(6):1281-1285
pubmed: 31147736
Genetics. 1972 May;71(1):157-84
pubmed: 4624779
Science. 2023 Aug 25;381(6660):eadg4521
pubmed: 37410869
Nature. 2018 Apr;556(7701):339-344
pubmed: 29643504
Cancer Cell. 2017 Feb 13;31(2):240-255
pubmed: 28089890
Dev Cell. 2017 Jun 19;41(6):638-651.e5
pubmed: 28633018
J Pediatr. 2013 Oct;163(4):1085-94
pubmed: 23810129
Epigenomics. 2019 Dec;11(16):1827-1837
pubmed: 31755744
Science. 2019 Nov 15;366(6467):843-849
pubmed: 31727829
Acta Cytol. 2020;64(6):511-519
pubmed: 32570234
Nature. 2015 Aug 6;524(7563):47-53
pubmed: 26168399
Cancer Res. 2017 Oct 1;77(19):5272-5286
pubmed: 28775166
Genes Dev. 2015 Oct 1;29(19):2010-21
pubmed: 26404941
Genetics. 1929 Mar;14(2):180-222
pubmed: 17246573
Cell. 2006 Oct 6;127(1):99-111
pubmed: 17018280
Cell. 2014 Apr 24;157(3):624-35
pubmed: 24766808
Genetics. 2008 Jun;179(2):737-46
pubmed: 18558649
Science. 2007 Aug 17;317(5840):916-24
pubmed: 17702937
Nat Struct Mol Biol. 2015 Sep;22(9):712-9
pubmed: 26301997
Pediatrics. 2003 Apr;111(4 Pt 1):777-84
pubmed: 12671111
Science. 2011 Aug 19;333(6045):1026-30
pubmed: 21852501
Science. 2003 Jun 27;300(5628):2055
pubmed: 12702809
Nature. 2013 Aug 15;500(7462):296-300
pubmed: 23863942
Nat Commun. 2016 Feb 15;7:10754
pubmed: 26876972
Mol Biol Cell. 2013 May;24(9):1274-89
pubmed: 23468524
Elife. 2016 Jul 29;5:
pubmed: 27472900
Elife. 2016 Mar 07;5:e10996
pubmed: 26949255
Cell Rep. 2019 Nov 19;29(8):2473-2488.e5
pubmed: 31747614

Auteurs

Eduardo M Torres (EM)

Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA. eduardo.torres@umassmed.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH